A Study of HS-10516 in Patients With Advanced Clear Cell Renal Cell Carcinoma
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT06049030 |
|
Recruitment Status :
Not yet recruiting
First Posted : September 21, 2023
Last Update Posted : September 26, 2023
|
Sponsor:
Jiangsu Hansoh Pharmaceutical Co., Ltd.
Information provided by (Responsible Party):
Jiangsu Hansoh Pharmaceutical Co., Ltd.
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Not yet recruiting |
|---|---|
| Estimated Primary Completion Date : | September 25, 2024 |
| Estimated Study Completion Date : | September 25, 2025 |